MedTrace Logo

Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation

NCT03908736 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-05-20

No results posted yet for this study

Summary

This is a study to assess the effect of dietary zinc supplementation to mitigate biomarkers of metal toxicity in exposed tribal populations.

Conditions

  • DNA Damage
  • Immune System Disorder

Interventions

DRUG

Zinc Picolinate 15 Mg

zinc picolinate, 15 mg/day for 6 months

Sponsors & Collaborators

  • University of New Mexico

    lead OTHER

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-19
Primary Completion
2027-07-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03908736 on ClinicalTrials.gov